Cognitive Impairment After COVID-19—A Review on Objective Test Data

Posted on | Posted on John Murphy | Leave a Comment on Cognitive Impairment After COVID-19—A Review on Objective Test Data

Authors: Rania Daroische1*, Mathilde S. Hemminghyth1,2, Thomas H. Eilertsen1, Monica H. Breitve1,2,3 and Luiza J. Chwiszczuk2,3 Objective: The aim was to conduct a review on the literature on objective cognitive impairment in patients after COVID-19. Methods: We performed a literature review and searched Ovid Medline in February 2021 based on a PECO scheme. Results: Twelve articles met all inclusion criteria. Total patient sample […]

Prevalence of anosmia and ageusia symptoms among long-term effects of COVID-19.

Posted on | Posted on John Murphy | Leave a Comment on Prevalence of anosmia and ageusia symptoms among long-term effects of COVID-19.

Authors: Moraschini V1, Reis D1, Sacco R2, Calasans-Maia MD3 COVID‐19 is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) that currently presents the greatest, most challenging health concern worldwide. Since the first reports of the disease in December 2019, clinicians and scientists have endeavored to understand the main symptoms, risk factors, and prognosis of […]

Characteristics of SARS-CoV-2 and COVID-19

Posted on | Posted on John Murphy | Leave a Comment on Characteristics of SARS-CoV-2 and COVID-19

Authors: Ben Hu, Hua Guo, Peng Zhou & Zheng-Li Shi  Nature Reviews Microbiology volume 19, pages141–154 (2021) Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that emerged in late 2019 and has caused a pandemic of acute respiratory disease, named ‘coronavirus disease 2019’ (COVID-19), which threatens human health and public safety. In this Review, we […]

COVID-19 related concerns of people with long-term respiratory conditions: a qualitative study

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 related concerns of people with long-term respiratory conditions: a qualitative study

Authors: Keir E. J. Philip,  Bradley Lonergan, Andrew Cumella, Joe Farrington-Douglas, Michael Laffan & Nicholas S. Hopkinson BMC Pulmonary Medicine volume 20, Article number: 319 (2020)  Abstract Background The COVID-19 pandemic is having profound psychological impacts on populations globally, with increasing levels of stress, anxiety, and depression being reported, especially in people with pre-existing medical conditions who appear to be particularly vulnerable. There are limited data […]

The characteristics and evolution of pulmonary fibrosis in COVID-19 patients as assessed by AI-assisted chest HRCT

Posted on | Posted on John Murphy | Leave a Comment on The characteristics and evolution of pulmonary fibrosis in COVID-19 patients as assessed by AI-assisted chest HRCT

Authors: Jia-Ni Zou , Liu Sun , Bin-Ru Wang , You Zou , Shan Xu, Yong-Jun Ding, Li-Jun Shen, Wen-Cai Huang, Xiao-Jing Jiang, Shi-Ming Chen  Published: March 23, 2021 https://doi.org/10.1371/journal.pone.0248957 Abstract The characteristics and evolution of pulmonary fibrosis in patients with coronavirus disease 2019 (COVID-19) have not been adequately studied. AI-assisted chest high-resolution computed tomography (HRCT) was used to […]

The incidence, clinical characteristics, and outcomes of pneumothorax in hospitalized COVID-19 patients: A systematic review

Posted on | Posted on John Murphy | Leave a Comment on The incidence, clinical characteristics, and outcomes of pneumothorax in hospitalized COVID-19 patients: A systematic review

Authors: Woon H. Chong,a,⁎Biplab K. Saha,bKurt Hu,c and Amit Chopraa Abstract Background Pneumothorax has been frequently described as a complication of COVID-19 infections. Objective In this systematic review, we describe the incidence, clinical characteristics, and outcomes of COVID-19-related pneumothorax. Methods Studies were identified through MEDLINE, Pubmed, and Google Scholar databases using keywords of “COVID-19,” “SARS-CoV-2,” “pneumothorax,” “pneumomediastinum,” […]

Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease

Posted on | Posted on John Murphy | Leave a Comment on Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease

Authors: Timothy Cardozo 1 and Ronald Veazey 2 Abstract Aims of the study Patient comprehension is a critical part of meeting medical ethics standards of informed consent in study designs. The aim of the study was to determine if sufficient literature exists to require clinicians to disclose the specific risk that COVID‐19 vaccines could worsen disease upon exposure to […]

U.S. probing Moderna vaccine for higher heart inflammation risk – Washington Post

Posted on | Posted on John Murphy | Leave a Comment on U.S. probing Moderna vaccine for higher heart inflammation risk – Washington Post

Authors: Reporting by Shubham Kalia in Bengaluru; Editing by Krishna Chandra Eluri and Ramakrishnan M. Aug 19 (Reuters) – U.S. health officials are investigating reports that Moderna Inc’s (MRNA.O) COVID-19 vaccine may be linked to a higher risk of a rare heart condition in younger adults than previously thought, the Washington Post reported late on Thursday, citing […]

Scientists blast U.S. push for Covid vaccine booster shots as premature, say data isn’t compelling

Posted on | Posted on John Murphy | Leave a Comment on Scientists blast U.S. push for Covid vaccine booster shots as premature, say data isn’t compelling

PUBLISHED THU, AUG 19 20211:44 PM EDTUPDATED THU, AUG 19 20216:27 PM EDT Authors: Berkeley Lovelace Jr.@BERKELEYJR KEY POINTS Scientists sharply criticized the Biden administration’s push to widely distribute Covid booster shots, saying the data provided by U.S. officials wasn’t compelling. While data suggests there is a reduction in protection against mild and moderate disease, […]

Delta is surging, but is another variant on the way? Here’s what to know about lambda

Posted on | Posted on John Murphy | Leave a Comment on Delta is surging, but is another variant on the way? Here’s what to know about lambda

Ben Sessoms, The Charlotte Observer   The delta variant is by far the dominant strain of the coronavirus in North Carolina and the rest of the country, but experts say there are also other variants to watch. Before delta, there was alpha, beta and gamma. Now there is another, lambda, which is primarily spreading in South America. […]